JSC
IBB icon

Jackson Square Capital’s iShares Biotechnology ETF IBB Stock Holding History

Jackson Square Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$5K – 228
2020
Q3 		$5K Buy
+40
New +$5.43K ﹤0.01% 299

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Jackson Square Capital's IBB Position: Q4 2020 in Review

Jackson Square Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 40 shares — an estimated $5K sold.

Jackson Square Capital first reported a position in IBB in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

  • Jackson Square Capital reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 40 iShares Biotechnology ETF shares in Q4 2020, an estimated $5K.
  • Jackson Square Capital first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 1 quarter.
  • Jackson Square Capital's iShares Biotechnology ETF position peaked at $5K in Q3 2020.
  • 856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.